congenital hereditary endothelial dystrophy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,548 results for “congenital hereditary endothelial dystrophy”

Trials

View all 6703 →

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

30 participants · First posted Apr 14, 2021

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study

14 participants · First posted Jul 15, 2016

Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy

First posted Aug 13, 2025

Drugs

View all 200 →

Adeno-Associated Virus 8 therapy (congenital hereditary endothelial dystrophy)

Fuchs' Endothelial Corneal Dystrophy (Prime Medicine)

DT-168

Organizations

View all 12 →

Dyne Therapeutics

United States

Sarepta Therapeutics, Inc.

United States

Biora Therapeutics

United States

News

View all 1633 →

FDA Grants Rare Pediatric Disease and Orphan Drug Designations to Six Gene Therapies

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1A

Aurion Biotech's Cell Therapy Shows Promise in Reducing Glare and Improving Vision in Corneal Edema

Page 1 of 855